I-Mab (IMAB) announced Thursday that Phillip Dennis has been appointed Chief Medical Officer, effective June 17, 2024.
As CMO, Dennis will lead the global clinical development efforts of the Company and will be a member of I-Mab's Executive Leadership Team.
Dennis brings over two decades of experience in oncology drug development.
Prior to joining I-Mab, Dennis had served as Vice President of Lung Cancer Strategy and Global Project Head at Sanofi.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.